Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtre
Ajouter des filtres








Gamme d'année
1.
Acta Pharmaceutica Sinica ; (12): 1557-1565, 2023.
Article Dans Chinois | WPRIM | ID: wpr-978722

Résumé

Activity-based protein (proteomic) profiling (ABPP) has emerged as a key component of the broad field of chemical techniques capable of directly analyzing enzyme activity in living systems. With the deepening of research on electrophilic warheads and nucleophilic amino acids, and the continuous proposal and improvement of effective development strategies, the application of amino acid-targeting active probes in various biological systems has facilitated the identification, development of new targets in various disease contexts and discovery of inhibitors. The purpose of this review is to summarize the latest progress in the design and application of active probes targeting specific amino acids, in order to provide support for the further development of amino acid-targeted covalent inhibitordrugs.

2.
Acta Pharmaceutica Sinica ; (12): 1275-1282, 2023.
Article Dans Chinois | WPRIM | ID: wpr-978693

Résumé

Based our previous work, twelve purine derivatives were designed and synthesized as dual modulators of GPR119 and DPP-4by conjugating the GPR119 activating and DPP-4 inhibiting fragments with the position 6 and 9 of purine core via an approach of merged pharmacophores. Compound 11, bearing 2-fluoro-4-methylsulphonyl anilide and cyanopyrrolidine moieties, exhibited the most potent GPR119 agonistic activities (EC50 = 0.33 μmol·L-1, IA = 71.1%) and DPP-4 inhibitory (58.4% inhibition at 10 μmol·L-1, 21.2% inhibition at 1 μmol·L-1) activities in the in vitro antidiabetic study. Subsequently, we performed studies on structure activity relationships and molecular docking to guide the further drug design.

3.
Acta Pharmaceutica Sinica ; (12): 2834-2842, 2020.
Article Dans Chinois | WPRIM | ID: wpr-862299

Résumé

G protein-coupled receptor 119 (GPR119) has been a promising target for the treatment of type 2 diabetes. It can not only directly promote insulin secretion, but also indirectly increase insulin secretion by stimulating the release of glucose-dependent GIP/CLP-1 without causing hypoglycemia. The remarkable advantages of small molecule GPR119 agonists make it one of the research hotspots for the development of type 2 diabetes drugs. This article reviews the anti-diabetic small molecules based on the GPR119 target in the past five years.

4.
Acta Pharmaceutica Sinica ; (12): 33-37, 2020.
Article Dans Chinois | WPRIM | ID: wpr-780557

Résumé

The resistance and dose limitation of tumors is a serious obstacle to cytotoxic drug therapy in the field of medical oncology. Nitric oxide (NO) is a powerful adjuvant for tumor hypersensitivity for traditional chemotherapy and radiation therapy. The concentration of NO plays an important role in affecting its anti-tumor effect. This review summarizes the mechanism of concentration-dependent effects of NO on tumor cells and the mechanism of chemotherapy sensitization. It provides evidence for rational use of NO to exert anti-tumor effects, and overcoming multidrug resistance and anti-tumor drug development.

5.
Acta Pharmaceutica Sinica ; (12): 366-372, 2019.
Article Dans Chinois | WPRIM | ID: wpr-780355

Résumé

@#In this paper, multifunctional silver-graphene quantum dot nanoparticles coated with phospholipids (ADG-DDPC) were prepared and their properties were evaluated <italic>in vitro</italic>. Cationic phospholipids 1,2-diolefinoxy-3-trimethy-laminopropane (DOTAP) was absorbed first onto the surface of the core of silver nanoparticle (AgNPs) through the mutual attraction between the positive and negative charge. Based on the principle of phase transformation and hydrophobic interaction, dstearyl-phosphatidylglycolamine-polyethylene-glycol-cyclic-cRGD peptide (DSPE-PEG<sub>2000</sub>-cRGD) self-assembled onto the outlayer of DOTAP of AgNPs. A stable multifunctional nano-preparation was formed and its ultraviolet absorption, particle size distribution, morphology,<italic>in vitro</italic> release behavior, ability to kill cancer cells and cell uptake were studied. The maximum UV absorption of the synthesized nanometer preparation was about 400 nm. Malvern particle size meter and transmission electron microscope showed that the particle size of the nano- preparation was about 30-40 nm and its particle size distribution was uniform. The <italic>in vitro</italic> release of nano-preparation was positively correlated with the concentration of H<sub>2</sub>O<sub>2</sub>. The IC<sub>50</sub> value of AgNPs for tumor cells was (347.78 ± 0.06) ng·mL<sup>-1</sup>, and the IC<sub>50</sub> value of ADG-DDPC for tumor cells was (209.68 ± 0.09) ng·mL<sup>-1</sup>, indicating that ADG-DDPC possessed a stronger cytotoxicity than that of AgNPs. Cell uptake experiment showed that ADG-DDPC could be absorbed by tumor cells and exhibited fluoresce inside those cells. In conclusion, ADG-DDPC was successfully prepared, and <italic>in vitro</italic>characterization study pointed to that the nano-preparation exhibits a higher antitumor activity than AgNPs.

SÉLECTION CITATIONS
Détails de la recherche